APA (7th ed.) Citation

EM, D., J, M., M, A., E, R., M, R., HT, H., . . . P, K. (2018). Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome. JCI insight, 3(12), . https://doi.org/10.1172/jci.insight.98333

Chicago Style (17th ed.) Citation

EM, Dykens, Miller J, Angulo M, Roof E, Reidy M, Hatoum HT, Willey R, Bolton G, and Korner P. "Intranasal Carbetocin Reduces Hyperphagia in Individuals with Prader-Willi Syndrome." JCI Insight 3, no. 12 (2018). https://doi.org/10.1172/jci.insight.98333.

MLA (9th ed.) Citation

EM, Dykens, et al. "Intranasal Carbetocin Reduces Hyperphagia in Individuals with Prader-Willi Syndrome." JCI Insight, vol. 3, no. 12, 2018, https://doi.org/10.1172/jci.insight.98333.